Advances in breast cancer treatment over the last 20 years

Highlights from BGICC 2020

The age of genomic profiling

Long-term toxicities in paediatric ALL

Identifying cancer susceptibility genes in paediatric ALL

Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients

Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women with hormone receptor-positive breast cancer

Implementation of genetic testing in breast cancer patients

Cisplatin versus doxorubicin/cyclophosphamide as neoadjuvant treatment in germline BRCA carriers with HER2-negative BC

Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints

Precision medicine treatment in older AML: Results of Beat AML master trial

Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing